Yoga May Help Cancer Survivors Catch Quality Zzzs

Published Online: Thursday, November 14, 2013
Follow Pharmacy_Times:
New research published online on August 12, 2013, in the Journal of Clinical Oncology suggests that yoga may help cancer survivors sleep more and sleep better after treatment.

The study enrolled 410 cancer survivors who suffered from moderate to more severe sleep problems 2 to 24 months after they had been treated with surgery, chemotherapy, or radiation. Almost all patients were white women and 75% had had breast cancer. Participants were randomly assigned to receive standard care or standard care in addition to a 4-week yoga intervention. The yoga intervention used the Yoga for Cancer Survivors program, in which participants attended two, 75-minute sessions per week. Sleep quality was assessed both before and after the intervention using the Pittsburgh Sleep Quality Index questionnaire and actigraphy sensors worn at night.

Patients in both groups improved their sleep patterns, but the yoga group improved significantly more than the control group. Overall, patients who did yoga improved their general sleep quality by 2 points on average, while control-group patients improved on an average of 1.1 points. Those who did yoga also saw greater improvements in daytime sleepiness and the amount of time spent sleeping compared with those who did not do yoga.

The results also indicated that participants in the yoga group reduced their use of sleep aids by 21% per week, while participants in the control group increased their use of sleep aids by 5% each week.

Related Articles
Citing a risk of spreading unsuspected cancer, the FDA is advising against the use of laparoscopic power morcellators in the removal of the uterus or fibroids in the majority of women.
Amgen has discontinued its studies on rilotumumab in advanced gastric cancer after an increased number of deaths were reported among patients receiving rilotumumab and chemotherapy, compared with those only undergoing chemotherapy.
Clinical practice guidelines for the diagnosis and treatment of certain types of cancer are surprisingly unstandardized.
A new liquid drug formulation from Teva Pharmaceutical Industries Ltd. will allow some cancer patients to see their therapy administered faster.
Latest Issues
$auto_registration$